Author archives: Zacks Equity Research

CaesarStone (CSTE) doesn’t possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Seattle Genetics (SGEN) doesn’t possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Mitsubishi UFJ (MUFG) records a fall in credit costs and a rise in gross profits in the third quarter of fiscal 2021.

The year-over-year improvement in the operating ratio at Old Dominion (ODFL) in Q4 bodes well.

Fiserv’s (FISV) fourth-quarter 2021 earnings and revenues are likely to have improved year over year.

C.H. Robinson’s (CHRW) Q4 results are hurt by high operating expenses. However, improved pricing and volumes across most service lines boost revenues.

H&R Block’s (HRB) second-quarter fiscal 2022 revenues were positively impacted by growth from Wave and strength in Emerald Card.

Novo Nordisk’s (NVO) earnings and revenues beat estimates in Q4. Sales are driven by growth in Diabetes and Obesity Care on higher GLP-1 revenues.

Raymond James Financial, Inc. (RJF) possesses solid growth attributes, which could help it handily outperform the market.

Infineon Technologies AG (IFNNY) possesses solid growth attributes, which could help it handily outperform the market.